Singapore is on track to become a significant gold hub, according to the World Gold Council. The shift in global gold trading towards the east is one of the key reasons driving this move. With gold consumption on the rise in major emerging markets, particularly in Asia, Singapore is strategically positioned to capitalize on this
0 Comments
In the realm of computer science, the pursuit of replicating the human brain’s neural networks has been ongoing for years. The goal is to develop artificial intelligence (AI) systems with unparalleled processing power. However, as these artificial neural networks become more sophisticated, they also become more energy-intensive. This inefficiency has prompted a Swiss start-up company
0 Comments
The translation of pediatric discharge instructions is a critical aspect of healthcare, ensuring that patients and their families receive accurate and understandable information regarding follow-up care and medication recommendations. A recent study compared the performance of professional translations, Google Translate, and ChatGPT in translating instructions from English into Spanish, Brazilian Portuguese, and Haitian Creole. The
0 Comments
OpenAI recently made headlines by hiring two top executives to join their team. Sarah Friar, previously CEO of Nextdoor and finance chief at Square, has been appointed as the company’s chief financial officer. This move is seen as a strategic decision to bolster the company’s financial capabilities and support its core research capabilities. Friar’s experience
0 Comments
The recent investigation into United Auto Workers President Shawn Fain by a federal court-appointed watchdog has raised serious concerns about potential corruption within the union. The monitor, Neil Barofsky, has accused Fain and other union leaders of obstructing the investigation and interfering with access to information. These allegations come as the union is engaged in
0 Comments
The recent unanimous support from the FDA advisory committee for the investigational drug donanemab in the treatment of early Alzheimer’s disease has brought new hope to patients with mild cognitive impairment and mild dementia. In an 11-0 vote, the Peripheral and Central Nervous System Drugs Advisory Committee concluded that the benefits of donanemab outweighed its
0 Comments